These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease. Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628 [TBL] [Abstract][Full Text] [Related]
4. Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism. Borah A; Mohanakumar KP Brain Res; 2010 Jul; 1344():192-9. PubMed ID: 20470760 [TBL] [Abstract][Full Text] [Related]
5. Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents. Borah A; Mohanakumar KP J Pineal Res; 2009 Nov; 47(4):293-300. PubMed ID: 19796048 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Shin JY; Park HJ; Ahn YH; Lee PH J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187 [TBL] [Abstract][Full Text] [Related]
7. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA. Alam M; Mayerhofer A; Schmidt WJ Behav Brain Res; 2004 May; 151(1-2):117-24. PubMed ID: 15084427 [TBL] [Abstract][Full Text] [Related]
8. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277 [TBL] [Abstract][Full Text] [Related]
9. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment. Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599 [TBL] [Abstract][Full Text] [Related]
10. Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Chen LW; Hu HJ; Liu HL; Yung KK; Chan YS Neuroscience; 2004; 126(4):941-53. PubMed ID: 15207328 [TBL] [Abstract][Full Text] [Related]
11. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Darmopil S; MartÃn AB; De Diego IR; Ares S; Moratalla R Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364 [TBL] [Abstract][Full Text] [Related]
13. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835 [TBL] [Abstract][Full Text] [Related]
14. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats. Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats. Glavan G; Zivin M Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820 [TBL] [Abstract][Full Text] [Related]
16. Postnatal development of tyrosine hydroxylase mRNA-expressing neurons in mouse neostriatum. Masuda M; Miura M; Inoue R; Imanishi M; Saino-Saito S; Takada M; Kobayashi K; Aosaki T Eur J Neurosci; 2011 Nov; 34(9):1355-67. PubMed ID: 22004548 [TBL] [Abstract][Full Text] [Related]
17. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Faherty CJ; Raviie Shepherd K; Herasimtschuk A; Smeyne RJ Brain Res Mol Brain Res; 2005 Mar; 134(1):170-9. PubMed ID: 15790541 [TBL] [Abstract][Full Text] [Related]
18. Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat. Lebel M; Chagniel L; Bureau G; Cyr M Neurobiol Dis; 2010 Apr; 38(1):59-67. PubMed ID: 20060905 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats. Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046 [TBL] [Abstract][Full Text] [Related]
20. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]